Sviluppa un wearable non invasivo per il monitoraggio continuo della glicemia basato su spettroscopia Raman.
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Series A Swiss Liom (formerly Spiden) extended its Series A by €13.9 million, bringing the round to €40.8 million, with support from existing investors and the entry of Red Bull Ventures. | $16.1M |